Enveric Biosciences, Inc. (ENVB) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Enveric Biosciences, Inc. (ENVB) quarterly cash flow statement — complete operating, investing & financing history

Quarterly statement

ENVB Cash Flow Statement

Enveric Biosciences, Inc. (ENVB) cash flow statement — 30-year operating, investing & financing cash flows

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21	Q3'21

Cash from Operations	-2.44M	-2.26M	-1.78M	-2.07M	-1.89M	-2.39M	-1.31M	-927.07K	-2.89M	-2.6M	-1.75M	-2.74M	-4.47M	-5.14M	-3.46M	-4.55M	-4.59M	-4.55M	-4.07M	-2.21M
Operating CF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating CF Growth %	-29.33%	5.63%	-36.09%	-123.82%	34.58%	7.96%	25.1%	66.17%	35.31%	49.42%	49.42%	39.78%	2.6%	-12.93%	14.88%	-106.26%	-126.78%	-43.85%	-80.77%	-460.32%
Net Income	-3.03M	-1.63M	-2.19M	-1.87M	-2.52M	-2.18M	-3.15M	-2.08M	-1.88M	-2.46M	-3.44M	-2.82M	-6.36M	-4.68M	-8.68M	-2.48M	-2.79M	-4.52M	-42.11M	-2.71M
Depreciation & Amortization	36.83K	37.24K	39.48K	40.37K	39.98K	81.02K	82.49K	84.81K	84.78K	85.41K	84.48K	95.84K	114.37K	113.33K	90.42K	121.1K	119.96K	103.72K	197.26K	173.7K
Stock-Based Compensation	125.11K	88.67K	240.23K	186.98K	206.26K	193.85K	471.68K	369.61K	369.61K	351.49K	364.73K	372.86K	879.74K	532.84K	529.37K	645.14K	677.54K	768.62K	7.77M	486.99K
Deferred Taxes	0	0	0	0	0	0	0	0	0	0	0	-3.36M	0	0	0	0	0	0	-7.45M	0
Other Non-Cash Items	-347.62K	19.6K	29.45K	-128.68K	0	-2.56K	411.6K	623	-18.57K	-21.44K	1.03M	2.73M	597.75K	-183.16K	3.86M	-3.18M	-1.92M	-275.97K	37.29M	-804.83K
Working Capital Changes	768.88K	-768.88K	100.14K	-299.95K	382.8K	-478.92K	877.34K	701.91K	-1.45M	-556.89K	205.84K	243.63K	298.27K	-922.49K	738.46K	340.45K	-675.27K	-621.3K	239.2K	650.35K
Change in Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Change in Payables	419.02K	-417.39K	-117.88K	-284.68K	289.98K	-301.28K	462.28K	161.76K	-1.66M	202.4K	0	-112.71K	-111.31K	653.71K	0	81.23K	-193.92K	6.02K	383.2K	139.47K
Cash from Investing	0	0	0	0	0	0	0	0	0	0	-38	0	16.85K	-5.17K	-6.19K	-18.57K	-53.89K	-505.51K	-189.72K	3.06M
Capital Expenditures	0	0	0	0	0	0	0	0	0	0	15	0	0	-5.17K	-6.19K	-18.57K	-53.89K	-505.51K	-189.72K	0
CapEx % of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisitions	0	0	0	0	0	0	0	0	0	0	0	0	16.87K	0	0	0	958.04K	0	0	3.06M
Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Investing	0	0	0	0	0	0	0	0	0	0	-53	0	0	0	0	0	-958.04K	0	0	0
Cash from Financing	5.84M	2.5M	2.69M	2.99M	449.1K	4.45M	463.45K	517.69K	34.43K	6.66M	-186.08K	-105K	-1.05M	0	-1	7.82M	958.04K	9.4M	0	-9
Debt Issued (Net)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Equity Issued (Net)	5.86M	2.5M	2.69M	2.99M	449.1K	4.45M	-1.32M	2.32M	51.68K	2.31M	0	0	-1.05M	0	-1	7.82M	0	9.4M	0	-9
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	0	0	0	1.08M	0	0	0	0	0	-1.05M	0	0	0	0	0	0	0
Other Financing	-18.84K	0	0	0	0	0	1.78M	-1.8M	-17.25K	4.35M	-186.08K	-105K	0	0	0	0	958.04K	0	0	0
Net Change in Cash	3.39M	231.28K	919.9K	907.78K	-1.44M	2.05M	-870.66K	-390.87K	-2.85M	4.07M	-1.98M	-2.81M	-5.48M	-5.16M	-3.48M	3.19M	-3.69M	4.34M	-4.09M	830.51K
Free Cash Flow	-2.44M	-2.26M	-1.78M	-2.07M	-1.89M	-2.39M	-1.31M	-927.07K	-2.89M	-2.6M	-1.75M	-2.74M	-4.47M	-5.14M	-3.47M	-4.57M	-4.64M	-5.05M	-4.26M	-2.21M
FCF Margin %	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FCF Growth %	-29.33%	5.63%	-36.09%	-123.82%	34.58%	7.96%	25.1%	66.17%	35.31%	49.47%	49.51%	40.02%	3.73%	-1.74%	18.53%	-107.1%	-129.44%	-31.72%	-89.2%	-460.32%
FCF per Share	-0.61	-1.49	-1.68	-6.62	-8.74	-15943.88	-24.03	-7.91	-24.64	-22.16	-17.08	-26.73	-43.56	-50.15	-33.83	-44.56	-52.83	-71.60	-110.37	-57.64
FCF Conversion (FCF/Net Income)	0.81x	1.38x	0.81x	1.11x	0.75x	1.09x	0.42x	0.44x	1.54x	1.06x	0.51x	0.97x	0.70x	1.10x	0.40x	1.83x	1.64x	1.01x	0.10x	0.81x
Interest Paid	0	0	0	0	0	0	0	0	0	0	0	0	0	0	135	0	0	0	0	0
Taxes Paid	0	0	0	0	0	0	-24K	0	0	24K	2.91K	6.59K	0	0	0	0	0	0	0	0